Abstract: This invention provides methods of generating natural killer (NK) cells and dendritic cells (DCs). The methods utilize human hemangioblasts as intermediate cells to generate the NK cells and DCs. In various embodiments, the methods do not require the use of stromal feeder layers.
Type:
Application
Filed:
August 21, 2014
Publication date:
May 21, 2015
Applicant:
Stem Cell & Regenerative Medicine International, Inc.
Abstract: This invention provides methods of generating natural killer (NK) cells and dendritic cells (DCs). The methods utilize human hemangioblasts as intermediate cells to generate the NK cells and DCs. In various embodiments, the methods do not require the use of stromal feeder layers.
Type:
Grant
Filed:
December 1, 2010
Date of Patent:
September 2, 2014
Assignee:
Stem Cell & Regenerative Medicine International, Inc.
Abstract: The present invention provides a method of generating megakaryocytes and platelets. In various embodiments, method involves the use of human embryonic stem cell derived hemangioblasts for differentiation into megakaryocytes and platelets under serum and stromal-free condition. In this system, hESCs are directed towards megakaryocytes through embryoid body formation and hemangioblast differentiation. Further provided is a method of treating a subject in need of platelet transfusion.
Type:
Application
Filed:
December 3, 2010
Publication date:
December 13, 2012
Applicant:
Stem Cell & Regenerative Medicine International, Inc.
Abstract: This invention provides methods of generating natural killer (NK) cells and dendritic cells (DCs). The methods utilize human hemangioblasts as intermediate cells to generate the NK cells and DCs. In various embodiments, the methods do not require the use of stromal feeder layers.
Type:
Application
Filed:
December 1, 2010
Publication date:
November 8, 2012
Applicant:
Stem Cell & Regenerative Medicine International, Inc.